| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | - | 1.827 | 8.966 | 14.217 |
| Total Income - EUR | - | - | - | - | - | - | - | 1.839 | 8.967 | 16.228 |
| Total Expenses - EUR | - | - | - | - | - | - | - | 14.258 | 14.031 | 14.988 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | - | -12.420 | -5.064 | 1.240 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | - | -12.438 | -5.154 | 753 |
| Employees | - | - | - | - | - | - | - | 1 | 1 | 1 |
Check the financial reports for the company - Nbcliniq Neurofeedback S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | - | 23.709 | 21.376 | 19.006 |
| Current Assets | - | - | - | - | - | - | - | 798 | 1.269 | 2.399 |
| Inventories | - | - | - | - | - | - | - | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | - | 0 | 0 | 0 |
| Cash | - | - | - | - | - | - | - | 798 | 1.269 | 2.399 |
| Shareholders Funds | - | - | - | - | - | - | - | -12.398 | -17.514 | -16.663 |
| Social Capital | - | - | - | - | - | - | - | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | - | 36.905 | 40.158 | 38.068 |
| Income in Advance | - | - | - | - | - | - | - | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8699 - 8699" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Nbcliniq Neurofeedback S.r.l.